TGF-beta inhibits vascular smooth muscle cell proliferation through down regulation of cyclin A

  • Sakakibara K
  • Kubota K
  • Worku B
 et al. 
  • 3

    Readers

    Mendeley users who have this article in their library.
  • N/A

    Citations

    Citations of this article.

Abstract

Smooth muscle cell (SMC) proliferation contributes to the development of intimal hyperplasia. In this study, we explore the mechanism by which TGF-β, a potent endogenous growth inhibitor of SMCs, affects cell cycle progression. Method: (Cells-A10 vascular SMCs) (SMC proliferation - 3H-thymidine) (protein levels of cyclin kinase inhibitors, P21,P27 and cyclin A - Western Blotting) (cyclin A mRNA - Northern blotting) (cyclin A gene expression - luciferase reporter containing cyclin A promoter) Results: TGF-β (5 ng/ml), which produced a 30% decrease in A10 SMC DNA synthesis, has been shown in other cellular systems to control proliferation by upregulating P21 and P27, two proteins that inhibit cell-cycle progression. Thus, we examined the effect of TGF-β on P21 and P27 in vascular SMC. We found no significant alteration in P21/P27 protein levels following stimulation of SMC with TGF-β for 5, 12 and 24 hrs. We then evaluated the effect of TGF-β on protein levels of cyclin A, a critical cell cycle protein down stream from P21/27 required for G1/S transition and completion of S. TGF-β (5 ng/ml) produced a 48.4 ± 17.5% decrease in cyclin A protein that was maximal at 17 hrs (p < 0.05) (Fig. 1). To determine if this reduction is the result of a decrease in cyclin A expression, we examined the level of cyclin A mRNA in A10 cells. We found a 50.2 ± 19.6% (p < 0.05) reduction in cyclin A mRNA following 17 hrs stimulation with TGF-β (5 ng/ml) (Fig. 2). To test whether TGF-β acts directly on the cyclin A promoter to reduce transcription, we transfected A10 cells with a luciferase reporter plasmid which contains the -516 to +245 region of the human cyclin A promoter. After transfection (3 hrs), cells were treated with TGF-β (5 ng/ml) for 17hrs. Lucifease activity in the TGF-β treated cells was decreased by 63.0 ± 12.0% (p < 0.05), suggesting that the cyclin A promoter activity is suppressed by TGF-β. Conclusion: Our data suggest that TGF-β directly inhibits cyclin A expression in SMC through an interaction with its proximal promoter. TGF-β appears to have no effect on the cell cycle inhibitors P21 and P27. Strategies that enhance the inhibitory effect of TGF-β on SMC proliferation and block its effect on matrix protein production will diminish the formation of intimal hyperplasia

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Authors

  • K. Sakakibara

  • K. Kubota

  • B. Worku

  • S. Hollenbeck

  • P. Faries

  • B. Liu

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free